Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 10;19(1):543.
doi: 10.1186/s13063-018-2921-z.

The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial

Affiliations

The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial

Pernille Gabel et al. Trials. .

Abstract

Background: Colorectal cancer screening participation is a preference-sensitive choice, in which trade-offs between benefits and harms must be made by individual citizens. Often the decision is made without any contact with healthcare professionals. Citizens with lower educational attainment tend to participate less in colorectal cancer screening than citizens with average educational attainment. Further, they tend to have lower levels of knowledge about colorectal cancer screening. Providing lower educational attainment citizens with a targeted decision aid embracing their diverse information needs might increase these citizens' ability to make informed decisions. The aim of this trial is to test the effectiveness of such a newly developed self-administered decision aid.

Methods: The LEAD (Lower Educational Attainment Decision aid) trial will be conducted as a two-arm randomized controlled trial among 10,000 50-74-year-old citizens, resident in the Central Denmark Region not yet invited to take up colorectal cancer screening. Citizens will receive a baseline questionnaire. Respondents will be allocated into the intervention or the control groups. Citizens in the intervention group will receive the decision aid whereas the control group will not. Those who return a stool sample within 45 days after receiving the screening invitation and those with medium or higher educational attainment are excluded. Both groups will receive a follow-up questionnaire 90 days after being invited to colorectal cancer screening. A historic cohort consisting of 5000 50-74-year-old citizens resident in the Central Denmark Region, having received their screening invitation in the beginning of 2017 will be included. This cohort will receive a follow-up questionnaire 6-9 months after they received the screening invitation. Informed choice will be evaluated by assessing levels of knowledge, attitudes, and screening uptake. Analyses will be conducted as intention-to-treat analyses. Additionally, differences between levels of worry and decisional conflict between groups will be assessed as secondary outcomes.

Discussion: This trial will evaluate whether a targeted decision aid is a feasible way of enhancing informed choice among lower educational attainment citizens in colorectal cancer screening. Further, it may guide decisions about providing information material in cancer screening in general.

Trial registration: ClinicalTrials.gov, NCT03253888 . Registered on 17 August 2017.

Keywords: Cancer screening; Colorectal cancer; Decision aid; Lower educational attainment; Randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The Danish Data Protection Agency gave permission to collect and hold survey data and obtain registry data (J.no.: 2012-58-006 / Case no.: 1-16-02-94-16). Further the study achieved clearance at The Danish Patient Safety Authorities (J.no.: 3-313-1729-1) and the Central Denmark Region Committees on Health Research Ethics (143/2016). The trial is registered in ClinicalTrials.gov (NCT03253888) (see Additional file 4).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Participant flow chart. Figure depicting the data collection, interventions, and participant flow in the trial
Fig. 2
Fig. 2
Schedule of enrolment, intervention, and assessments. Figure depicting the enrolment, intervention, and assessments according to SPIRIT 2013 statement [46]. § Assessed only in the historic cohort. BD background data, obtained from Statistics Denmark. Follow-up occurs throughout a period of 12 weeks. The final data will be obtained from the screening program IT system when all follow-up data have been collected. The complete data will then be merged with background data from Statistics Denmark

Similar articles

Cited by

References

    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon: International Agency for Research on Cancer; 2013.
    1. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549. doi: 10.1111/j.1572-0241.2008.01875.x. - DOI - PubMed
    1. Parra-Blanco A, Gimeno-Garcia AZ, Quintero E, Nicolas D, Moreno SG, Jimenez A, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45:703–712. doi: 10.1007/s00535-010-0214-8. - DOI - PubMed
    1. van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AH, Reijerink JC, et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer. 2013;49:2321–2330. doi: 10.1016/j.ejca.2013.03.007. - DOI - PubMed
    1. Fransen MP, Dekker E, Timmermans DR, Uiters E, Essink-Bot ML. Accessibility of standardized information of a national colorectal cancer screening program for low health literate screening invitees: A mixed method study. Patient Educ Couns. 2017;100:327–336. doi: 10.1016/j.pec.2016.09.004. - DOI - PubMed

Publication types

MeSH terms

Substances